Thursday, July 9, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “MENS”

99 pharma patents match "MENS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 99
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 99 pharmaceutical patents matching "MENS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

99 results for “MENS” · 30,257 patents in full index Clear search

  1. EP 2846808

    ZUCKERZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON HÄMOPHILIE A UND/ODER VON-WILLEBRAND-SYNDROM

    CSL BEHRING GMBH [DE] · Granted Mar 18, 2015 · Expires Mar 13, 2035

    granted

  2. US 8858945

    Three-dimensional structure of complement receptor type 2 and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  3. US 8741589

    Monitoring two dimensions of diabetes pathogenesis

    The Regents of the University of California · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  4. US 8734825

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted May 27, 2014 · Expires May 22, 2034

    granted

  5. US 8680084

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  6. US 8673332

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  7. US 8563023

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  8. EP 2624836

    BEPOTASTIN-ZUSAMMENSETZUNG

    BAUSCH & LOMB [US] · Granted Aug 14, 2013 · Expires Aug 9, 2033

    granted

  9. US 8465737

    Three-dimensional structure of complement receptor type 2 and uses thereof

    The Regents of the University of Colorado · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  10. US 8450299

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  11. US 8415332

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  12. US 8349586

    Commensal strain of E. coli encoding an HIV GP41 protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  13. US 8338396

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  14. US 8128924

    Methods for using a three-dimensional stromal tissue to promote angiogenesis

    Theregen, Inc. · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted

  15. DE 202010004750

    Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  16. US 7858605

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  17. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  18. US 7772219

    Methods of hormonal treatment utilizing extended cycle contraceptive regimens

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  19. EP 2079529

    ANTIMIKROBIELLE ZUSAMMENSETZUNG MIT EINEM GEHALT AN BISPYRIDINIUMALKAN (OCTENIDIN-DIHYDROCHLORID)

    AIR LIQUIDE SANTE INT [FR] · Granted Jul 22, 2009 · Expires Jul 17, 2029

    granted

  20. US 7563593

    Method for preparing cell cultures from biological specimens for assaying secreted factors

    Precision Therapeutics, Inc. · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

  21. US 7368279

    Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 6, 2008 · Expires May 1, 2028

    granted

  22. EP 1847258

    Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate

    RENTSCHLER GMBH [DE] · Granted Oct 24, 2007 · Expires Oct 19, 2027

    granted

  23. CA 2628716

    PROCESSUS DE REGULATION DE LA DIMENSION DE PARTICULE

    ALPHAPHARM PTY LTD [AU] · Granted May 18, 2007 · Expires May 13, 2027

    granted

  24. US 7112415

    Method of preparing cell cultures from biological specimens for assaying a response to an agent

    Precision Therapeutics, Inc. · Granted Sep 26, 2006 · Expires Sep 21, 2026

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.